Keywords: sugen, moves, into, ph, iii, su101, said

Sugen Moves Into Ph III With SU101

Article | 21 January 1998

Print This

Sugen has said that it is initiating its first Phase III study of SU101,a platelet-derived growth factor receptor blocker, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in